AAAAAA

   
Results: 1-9 |
Results: 9
Benzophenone derivatives and related compounds as potent histamine H-3-receptor antagonists and potential PET/SPECT ligands
Authors: Sasse, A Ligneau, X Sadek, B Elz, S Pertz, HH Ganellin, CR Arrang, JM Schwartz, JC Schunack, W Stark, H
Citation: A. Sasse et al., Benzophenone derivatives and related compounds as potent histamine H-3-receptor antagonists and potential PET/SPECT ligands, ARCH PHARM, 334(2), 2001, pp. 45-52
Novel histaprodifen analogues as potent histamine H-1-receptor agonists inthe pithed and in the anaesthetized rat
Authors: Schlicker, E Kozlowska, H Kwolek, G Malinowska, B Kramer, K Pertz, HH Elz, S Schunack, W
Citation: E. Schlicker et al., Novel histaprodifen analogues as potent histamine H-1-receptor agonists inthe pithed and in the anaesthetized rat, N-S ARCH PH, 364(1), 2001, pp. 14-20
Complex interaction of ergovaline with 5-HT2A, 5-HT1B/1D, and alpha(1) receptors in isolated arteries of rat and guinea pig
Authors: Schoning, C Flieger, M Pertz, HH
Citation: C. Schoning et al., Complex interaction of ergovaline with 5-HT2A, 5-HT1B/1D, and alpha(1) receptors in isolated arteries of rat and guinea pig, J ANIM SCI, 79(8), 2001, pp. 2202-2209
Histaprodifens: Synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H-1-receptor agonists
Authors: Elz, S Kramer, K Pertz, HH Detert, H ter Laak, AM Kuhne, R Schunack, W
Citation: S. Elz et al., Histaprodifens: Synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H-1-receptor agonists, J MED CHEM, 43(6), 2000, pp. 1071-1084
New histamine H-3-receptor ligands of the proxifan series: Imoproxifan andother selective antagonists with high oral in vivo potency
Authors: Sasse, A Sadek, B Ligneau, X Elz, S Pertz, HH Luger, P Ganellin, CR Arrang, JM Schwartz, JC Schunack, W Stark, H
Citation: A. Sasse et al., New histamine H-3-receptor ligands of the proxifan series: Imoproxifan andother selective antagonists with high oral in vivo potency, J MED CHEM, 43(17), 2000, pp. 3335-3343
Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors
Authors: Glusa, E Pertz, HH
Citation: E. Glusa et Hh. Pertz, Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors, BR J PHARM, 130(3), 2000, pp. 692-698
Synthesis and autoradiographic evaluation of a novel high-affinity Tc-99m ligand for the 5-HT2A receptor
Authors: Pietzsch, HJ Scheunemann, M Kretzschmar, M Elz, S Pertz, HH Seifert, S Brust, P Spies, H Syhre, R Johannsen, B
Citation: Hj. Pietzsch et al., Synthesis and autoradiographic evaluation of a novel high-affinity Tc-99m ligand for the 5-HT2A receptor, NUCL MED BI, 26(8), 1999, pp. 865-875
Simple O-acylated derivatives of lysergol and dihydrolysergol-I: Synthesisand interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha(l) adrenergic receptors
Authors: Pertz, HH Brown, AM Gager, TL Kaumann, AJ
Citation: Hh. Pertz et al., Simple O-acylated derivatives of lysergol and dihydrolysergol-I: Synthesisand interaction with 5-HT2A, 5-HT2C and 5-HT1B receptors, and alpha(l) adrenergic receptors, J PHARM PHA, 51(3), 1999, pp. 319-330
Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, andelymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: Pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity
Authors: Pertz, HH Milhahn, HC Eich, E
Citation: Hh. Pertz et al., Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, andelymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: Pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity, J MED CHEM, 42(4), 1999, pp. 659-668
Risultati: 1-9 |